Rare diseases
Investigational molecules
Locations
Back to France659 clinical trials in Caen, France across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis
FranceStudy on the Effects of Inhaled Treprostinil for Patients with Idiopathic Pulmonary Fibrosis
FranceFranceStudy Comparing Radiotherapy Alone to Radiotherapy with Cisplatin for Patients with Sinus or Salivary Gland Tumors
FranceStudy on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis
FranceStudy on Atezolizumab and Resiquimod Sulfate with Radiotherapy for Patients with Advanced Solid Tumors
FranceTitle: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment
FranceStudy of Domvanalimab, Zimberelimab, and Chemotherapy for Patients with Advanced Esophageal or Gastric Cancer
FranceStudy Comparing Trastuzumab Deruxtecan with Chemotherapy for Patients with HER2-Low, Hormone Receptor Positive Breast Cancer After Endocrine Therapy Progression
FranceStudy Comparing Avelumab, Cetuximab, and Radiotherapy with Standard Treatments for Patients with Advanced Head and Neck Squamous Cell Carcinoma
FranceStudy of NP137 with carboplatin, paclitaxel and pembrolizumab combination therapy for patients with advanced endometrial or cervical cancer who had prior chemotherapy
FranceStudy of spartalizumab combined with FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, docetaxel) for patients with resectable gastric cancer before and after surgery
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple cancer types including head and neck squamous cell carcinoma, endometrial cancer, and multiple myeloma. Studies evaluate novel therapeutic combinations and treatment strategies.
Trials investigate targeted therapies and immunotherapy approaches for improved patient outcomes.
Studies examining prevention and treatment of respiratory infections, with focus on respiratory syncytial virus (RSV) in vulnerable populations. Investigation of novel antibiotics for prosthetic joint infections.
Research aims to develop effective preventive strategies and therapeutic interventions.
Research exploring treatments for heart failure prevention and management of cardiovascular conditions. Studies evaluate antiplatelet therapy strategies in elderly patients following interventional procedures.
Focus on improving cardiovascular outcomes through innovative therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
